Rating- BUY - All clear to improved industry profitability
时间:2024-09-29 02:51:50 阅读(143)
Ashok Leyland (AL) reported a robust performance in Q2, with a significant increase in Ebitda and recurring PAT by 29-32% q-o-q (2-3x y-o-y), aligning with Jefferies expectations. Volumes witnessed a notable growth of 10% y-o-y (+21% q-o-q), although ASP declined by 2% q-o-q. The Ebitda margin saw a substantial expansion of 120bp q-o-q, reaching 11.2%, primarily driven by operating leverage. The Ebitda/vehicle also reached an all-time high, rising by 9% q-o-q. The net debt showed a considerable reduction of 22% q-o-q to Rs 11bn, despite being higher compared to net cash at the end of FY23. Ashok Leyland anticipates an improvement in industry profitability in 2H, attributed to increased demand and a more favourable commodities environment.
Established in 1948, Ashok Leyland is the second-largest commercial vehicle manufacturer in India, boasting around 30% market share in medium and heavy commercial vehicles (MHCVs). The company has a diversified presence in buses, light commercial vehicles (LCVs), defence, and exports, and operates as part of the Hinduja Group. The price target of Rs 220 is derived from a 5.5x FY25 book value. Key risks to this outlook include a potential downturn in Indian truck demand.
猜你喜欢
- Global stocks follow Wall Street higher on interest rate hopes
- ITC Hotels demerger to unlock value; brokerages bullish, set ITC stock targets above Rs 500
- Jagannath Puri Rath Yatra 2023- Festival begins tomorrow; here’s a glimpse of the preparations – PHOTOS
- Gold outlook- No clear direction ahead of FOMC; wait for breakout above 51400 or below 50000 before buying
- Nifty to fall below 18000 or bulls to bring Santa Claus rally- 7 things to know before market opening bell
- Global Markets- Shares and bonds hit after Swiss and UK rate hikes
- Nifty to head to 16600 in coming weeks, use dips for buying, Bank Nifty positive; Buy SBI, Titan stocks
- ITC share price tops Rs 400, hits fresh all-time high, gains over 20% so far this year
- Investor Guide – Healthcare- Recent correction makes the space attractive